← Back to Search

Community Health Worker led curriculum for Vaccine Hesitancy

Led By Sheba George, PhD
Research Sponsored by Charles Drew University of Medicine and Science
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English Speaking
Self-identify as African American or Latinx
Must not have
Screening 3 weeks
Treatment Varies
Follow Upsix weeks from start of project
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will compare how well a COVID-19 curriculum led by LACDHS Community Health Workers helps safety-net patients get COVID-19 testing and vaccination, and how well it meets their other healthcare needs.

Eligible Conditions
  • Vaccine Hesitancy
  • COVID-19 Testing
  • Community Health Workers

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You are able to speak English.
You identify as either African American or Latinx.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six weeks from start of project
This trial's timeline: 3 weeks for screening, Varies for treatment, and six weeks from start of project for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Project Survey: Phenx toolkit - Attitudes and Behavior
Project Survey: Phenx toolkit - Perceived Coronavirus Threat
Project Survey: Phenx toolkit - Worry about COVID
Secondary outcome measures
Pre and Post Program Survey: Medical Mistrust Scale
Project Survey: Phenx toolkit - Intent to participate in COVID testing and vaccination
Sherer, et al.'s General Self-Efficacy Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Arm - CHW-led curriculum (Group 2)Experimental Treatment1 Intervention
Participants assigned to the intervention group will complete the same activities as Group 1 and be asked to participate in the virtual intervention, consisting of six-weekly group classes via Zoom, and six-weekly personalized teleconsultations (via phone call or Zoom) at a suitable time for both participants and CHWs. Study participants will receive 6 linguistically and ethnically concordant weekly two-hour group classes and personalized teleconsultations led by CHWs. The total time commitment for Group 2 will be a maximum of 20 hours (6 two-hour group classes, + 6 one hour personal session, + 2 half hour phone calls), over the next 6 weeks.
Group II: Control Arm - Standard Treatment (Group 1)Active Control1 Intervention
The standard care for the control arm will be: the LACDHS Vaccine Hesitancy Outreach Group calling patients once every month to remind patients of the need to be vaccinated and tested if needed. During the duration of the six weeks, the study participants will be exposed to the call from the LACDHS Vaccine Hesitancy Outreach Group. Participants will receive two phone calls six-weeks apart, where they will complete a pre-survey in the first phone call, and 2 surveys (post-survey and CDE survey) in the second phone call. The survey will measure their trust in medical institutions, rate their self-efficacy, and intention, knowledge, and perceptions on COVID-19 testing and vaccination.

Find a Location

Who is running the clinical trial?

Charles Drew University of Medicine and ScienceLead Sponsor
51 Previous Clinical Trials
6,921 Total Patients Enrolled
1 Trials studying Vaccine Hesitancy
600 Patients Enrolled for Vaccine Hesitancy
Los Angeles County Department of Public HealthOTHER_GOV
19 Previous Clinical Trials
550,897 Total Patients Enrolled
1 Trials studying Vaccine Hesitancy
236,000 Patients Enrolled for Vaccine Hesitancy
National Library of Medicine (NLM)NIH
38 Previous Clinical Trials
107,400 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~32 spots leftby Nov 2024